Literature DB >> 26493797

The minimal important difference for the St George's Respiratory Questionnaire in patients with severe COPD.

Jorrit B A Welling1, Jorine E Hartman1, Nick H T Ten Hacken1, Karin Klooster1, Dirk-Jan Slebos2.   

Abstract

The St George's Respiratory Questionnaire (SGRQ) is a validated, commonly used questionnaire for measuring quality of life in patients with chronic obstructive pulmonary disease (COPD). The current established minimal important difference (MID) for SGRQ scores in an average COPD population is -4 units. However, for patients with severe COPD, the MID has not been thoroughly validated. We re-determined the SGRQ MID for this patient group.115 severe COPD patients (forced expiratory volume in 1 s (FEV1) 26±9% of predicted, SGRQ score 62±11 units; mean±sd,) who participated in seven different bronchoscopic lung volume reduction clinical trials were included in the analysis. Anchor- and distribution-based methods were used to define the MID for SGRQ scores. FEV1, 6-min walk distance and residual volume were used as anchors.Combining both anchor- and distribution-based methods, we identified a SGRQ MID of -8.3 units at 1 month and -7.1 units at 6 months.This study proposes an alternative SGRQ MID for patients with severe COPD of -8.3 units at 1 month and -7.1 units at 6 months follow-up after intervention. Our new MID estimates could be applied for both interpreting SGRQ outcomes as well as sample size determination in future clinical trials investigating interventions in severe COPD patients.
Copyright ©ERS 2015.

Entities:  

Mesh:

Year:  2015        PMID: 26493797     DOI: 10.1183/13993003.00535-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  35 in total

Review 1.  Lung volume reduction surgery for diffuse emphysema.

Authors:  Joseph Em van Agteren; Kristin V Carson; Leong Ung Tiong; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-10-14

2.  First in Human Experience of the Performance of the New 5.5-LP Size Zephyr Endobronchial Valve.

Authors:  Karin Klooster; Marlies van Dijk; T David Koster; Dirk-Jan Slebos
Journal:  Respiration       Date:  2019-11-26       Impact factor: 3.580

3.  One-Year Follow-Up after Endobronchial Valve Treatment in Patients with Emphysema without Collateral Ventilation Treated in the STELVIO Trial.

Authors:  Karin Klooster; Jorine E Hartman; Nick H T Ten Hacken; Dirk-Jan Slebos
Journal:  Respiration       Date:  2016-12-15       Impact factor: 3.580

Review 4.  Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease.

Authors:  Joseph Em van Agteren; Khin Hnin; Dion Grosser; Kristin V Carson; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2017-02-23

5.  Endobronchial Valve Treatment in Emphysema Patients with a Very Low DLCO.

Authors:  Marlies van Dijk; Jorine E Hartman; Karin Klooster; Nick H T Ten Hacken; Huib A M Kerstjens; Dirk-Jan Slebos
Journal:  Respiration       Date:  2020-01-21       Impact factor: 3.580

6.  Identifying Responders and Exploring Mechanisms of Action of the Endobronchial Coil Treatment for Emphysema.

Authors:  Jorine E Hartman; Karin Klooster; Sonja W S Augustijn; Wouter H van Geffen; Justin L Garner; Pallav L Shah; Nick H T Ten Hacken; Dirk-Jan Slebos
Journal:  Respiration       Date:  2021-03-19       Impact factor: 3.580

7.  Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema.

Authors:  Karin Klooster; Arschang Valipour; Charles-Hugo Marquette; Jacques Boutros; Hervé Mal; Armelle Marceau; Pallav L Shah; Francesca Conway; Gaëtan Deslée; Arnaud Bourdin; Christophe Pison; Christian Grah; Martin Hetzel; Christian Schumann; Romain Kessler; Ralf-Harto Huebner; Dirk Skowasch; Kaid Darwiche; Peter Hammerl; Franz Stanzel; Michaela Bezzi; Hervé Dutau; Felix J F Herth; Dirk-Jan Slebos
Journal:  Respiration       Date:  2021-05-07       Impact factor: 3.580

8.  Lung volume reduction in emphysema: a pragmatic prospective cohort study.

Authors:  Christophe Dooms; Astrid Blondeel; Laurens J Ceulemans; Johan Coolen; Stephanie Everaerts; Heleen Demeyer; Thierry Troosters; Geert Verleden; Dirk Van Raemdonck; Wim Janssens
Journal:  ERJ Open Res       Date:  2021-05-31

9.  Effects of endobronchial coils for endoscopic lung volume reduction on sleep in COPD patients with advanced pulmonary emphysema.

Authors:  Karl-Josef Franke; Ulrike Domanski; Maik Schröder; Georg Nilius
Journal:  Sleep Breath       Date:  2020-08-26       Impact factor: 2.816

Review 10.  Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions.

Authors:  Peter G Gibson; Charlene M Prazma; Geoffrey L Chupp; Eric S Bradford; Mark Forshag; Stephen A Mallett; Steve W Yancey; Steven G Smith; Elisabeth H Bel
Journal:  Respir Res       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.